Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Ensuring global vaccine equity requires eliminating trade and regulatory barriers

Since the emergency use authorization of the first COVID-19 vaccine in December 2020, health experts have underscored that in order to combat the pandemic, vaccines must be widely available, accessible and reach people worldwide. To help make this a reality, the biopharmaceutical industry, governments and other stakeholders have been working tirelessly to scale up manufacturing and production and establish mechanisms for vaccine dose sharing to support equitable access globally. Today, COVID-19 vaccines have been administered across 180 countries, and production is expected to climb to 11 billion vaccine doses by the end of 2021.